PubMed Health⌕ Search

Biomedical subjects

Hak-Keung Yuen

Publications and source records attributed to Hak-Keung Yuen.

2 recordsLinked to original sources

Efficacy evaluation under type II censored plan with postclassified samples.

The main theme of this paper is efficacy evaluation under Type II censoring. Observations from a clinical trial are often postclassified into two groups in an effort to properly assess the efficacy of an intervention on each group. Thus, the numbers of observed lifetimes in the two groups are random outcomes. Parameter estimation and hypotheses testing under this postclassified setting are discussed. A numerical study is conducted to assess whether the results derived based on fixed sample sizes could be used in the postclassified case. The results would provide insight to practitioners in analyzing data observed under the postclassified case.

Clinical Trials as Topic↗

Design and analysis of survival data under an integrated type-II interval censoring scheme.

This article considers the planning of Type-II interval censored life tests for exponentially distributed lifetimes. In particular, we explore two criteria that are based on the minimization of the asymptotic variance of maximum likelihood estimator of the model parameter and the associated cost of the experiment. A numerical study is conducted to evaluate the "optimal" plans based on these two criteria. The results of this study should provide practitioners useful insight in planning a Type-II interval censoring life test.

Algorithms↗